Novartis Corporation -Discussion on key data concerning Novartis metabolic franchise, focusing on Galvus- Conference Call - Research and Markets offers a brief of 'Novartis Corporation' Conference Call.DUBLIN, Ireland -- The Novartis Corporation (NYSE NYSE See: New York Stock Exchange :NVS) Corporate Conference Call took place on 13-Jun-06 2:00pm ET. NVS discussed key data concerning its metabolic franchise, focusing on Galvus, a once-daily oral treatment option for type 2 diabetes type 2 diabetes n. See diabetes mellitus. . The Co. presented this on 06/13/2006 at the American Diabetes Association The American Diabetes Association, or the ADA, is an American health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of (ADA Ada, city, United States Ada (ā`ə), city (1990 pop. 15,820), seat of Pontotoc co., S central Okla.; inc. 1904. It is a large cattle market and the center of a rich oil and ranch area. ) Meeting in Washington, DC. More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/90579 This document provides a non-biased summary of the conference call detailing the key points and the full Q&A session. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion